Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Horizon Therapeutics (HZNP)
NASDAQ:HZNP
Holding HZNP?
Track your performance easily
See the Price Targets and Ratings of:
HZNP Analyst Ratings
Hold
0 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HZNP Stock 12 Month Forecast
Average Price Target
$116.50
▲(0.17% Upside)
| Highest Price Target$116.50 | Average Price Target$116.50 | Lowest Price Target$116.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Downgraded
09/01/23
H.C. Wainwright
Reiterated
08/09/23
Leerink Partners
Reiterated
05/31/23
Wells Fargo
Reiterated
05/16/23
Raymond James
Assigned
03/01/23
Guggenheim
Downgraded
12/13/22
Stifel Nicolaus
Downgraded
12/12/22
Piper Sandler
Downgraded
12/12/22
TD Cowen
Reiterated
11/30/22
Oppenheimer
Reiterated
11/03/22
UBS
$76
Hold
-34.65%
Downside
Reiterated
11/03/22
Horizon Therapeutics (HZNP) PT Raised to $76 at UBSUBS analyst Ashwani Verma raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $76.00 (from $71.00) while maintaining a Neutral rating.
Best Analysts Covering Horizon Therapeutics
Which Analyst Should I Follow If I Want to Buy HZNP and Sell After:
1 Month
xxx
Success Rate
15/28 ratings generated profit
Average Return
-0.07%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.57% of your transactions generating a profit, with an average return of -0.07% per trade.
3 Months
xxx
Success Rate
18/28 ratings generated profit
Average Return
+7.92%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +7.92% per trade.
1 Year
Success Rate
20/28 ratings generated profit
Average Return
+42.89%
reiterated a buy rating 2 years ago
Copying Ken Cacciatore's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +42.89% per trade.
2 Years
xxx
Success Rate
23/28 ratings generated profit
Average Return
+110.38%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.14% of your transactions generating a profit, with an average return of +110.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HZNP Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
HZNP Financial Forecast
HZNP Stock Forecast FAQ
What is HZNP’s average 12-month price target, according to analysts?
Based on analyst ratings, Horizon Therapeutics’s 12-month average price target is $116.50.
What is HZNP’s upside potential, based on the analysts’ average price target?
Horizon Therapeutics has 0.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HZNP a Buy, Sell or Hold?
Horizon Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Horizon Therapeutics’s price target?
The average price target for Horizon Therapeutics is $116.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $116.50 ,the lowest forecast is $116.50. The average price target represents 0.17% Increase from the current price of $116.3.
The highest analyst price target is $116.50 ,the lowest forecast is $116.50. The average price target represents 0.17% Increase from the current price of $116.3.
What do analysts say about Horizon Therapeutics?
Horizon Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of HZNP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.